Ackrell Capital Report on U.S. State-Legal Cannabis Market Size (2017)
Summary
The passage provides market size estimates for legal cannabis but contains no references to influential actors, financial flows, or misconduct. It offers no actionable investigative leads. 97% of U.S. population lives in a jurisdiction with some form of legal cannabis. 2017 U.S. state-legal cannabis market estimated at $8.0 billion. California accounts for $3.2 billion of that market.
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (1)
Tags
Related Documents (6)
Ackrell Capital Cannabis Market Forecast Lacks Direct Political or Financial Misconduct Leads
The document is a commercial market analysis of legal cannabis, containing no specific allegations, transactions, or connections to high‑profile officials or agencies. It offers no actionable investig Provides global cannabis consumption estimates and market size projections. Mentions countries with medical cannabis laws and predicts future recreational legalization. Outlines methodology based on
Ackrell Capital Cannabis Investment Report (Dec 2017) outlines market size and federal‑state regulatory landscape
The passage provides general industry data and describes federal policy context but offers no concrete names, transactions, dates, or actionable leads linking high‑level officials or agencies to misco U.S. state‑legal cannabis market estimated at $8.0 billion in 2017. Breakdown by state: California $3.2 B, Colorado $1.5 B, Washington $929 M, Oregon $470 M, other stat Federal law still prohibits al
Cannabis Industry Segmentation Overview – Product Sales by Category (Q3 2017)
The passage provides generic market data on cannabis product categories with no mention of influential individuals, agencies, financial flows, or misconduct. It lacks actionable leads or controversial Three main cannabis consumption categories: flower, concentrates, infused products. Q3 2017 sales distribution for CO, OR, WA: 51% flower, 23% concentrates, 14% edibles, 12% other. Infused products h
Ackrell Capital 2018 Cannabis Investment Report – Market Overview and Regulatory Landscape
The document is a commercial investment report providing market size estimates, regulatory summaries, and company listings for the cannabis industry. It contains no specific allegations, undisclosed f U.S. federal prohibition of cannabis remains, but state legalization is expanding (46 states with me Projected U.S. legal cannabis market could exceed $100 billion annually if federal legalization oc
Ackrell Capital Report on Cannabis Debt Financing
The document is a generic industry analysis of cannabis financing without any specific allegations, names, transactions, or controversial actions involving powerful actors. It offers no actionable inv Direct lenders are filling a financing gap for cannabis companies due to lack of bank loans. Debt costs for cannabis firms are 200‑500 basis points higher than other sectors. Valuations in the cannab
Report on Alternative Methods for Producing Cannabinoids
The document discusses technical aspects of cannabinoid synthesis with no mention of influential actors, financial flows, or misconduct. It offers no actionable investigative leads and contains inform Cannabinoids constitute <1% of dry cannabis weight. Chemical synthesis is costly, waste‑intensive, and slow. Synthetic biology offers faster, scalable, and greener production.
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.